Tavaborole (Kerydin) for Onychomycosis

Type: drug

Status: FDA Approved

Developer: Anacor Pharmaceuticals (now Pfizer)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026